This application is the United States national phase of International Application No. PCT/EP2020/061485 filed Apr. 24, 2020, and claims priority to Europe Patent Application No. 19305540.7 filed Apr. 26, 2019, the entire disclosures of which are hereby incorporated by reference in their entirety.
The present disclosure relates generally to medical injection devices for delivery of a fluid or liquid medicament. More particularly, the present disclosure relates to a needle cover adapted to be mounted on a tip of a medical injection device for covering a needle attached thereon. The disclosure also relates to a medical assembly including a medical injection device and a needle cover for enclosing the needle of the medical injection device.
Medical injection devices such as syringes are well known in the art. These devices typically include a container for containing a medical composition such as a liquid medicament. Said container usually includes an end piece in a form of a longitudinal tip defining a fluid path through which the medical solution is expelled. A needle may be attached to the tip in order to prick the patient's skin and to perform the injection of the medical composition.
In order to maintain sterility prior to use and to reduce the risk of incurring an accidental needle-stick, protection of the needle is important. Thus, a needle cover may be mounted on the tip of the barrel so as to enclose the needle. This renders the needle physically inaccessible by the persons around the device. The needle cover may include an inner shield, in a material with elastomeric properties, and may further include an outer shield, in rigid plastic, surrounding the inner shield. The inner needle shield ensures the sealing of the medical injection device. To that purpose, the inner needle shield includes a sealing portion that sealingly contacts the outer surface of the syringe's tip to provide a tight seal. The inner needle shield prevents any contamination of the medical composition from the outside environment, thereby assuring the container closure integrity. The inner needle shield further prevents any leakage of composition from the outlet of the needle to the external environment. To that purpose, the needle is preferably pricked in the inner needle shield.
Immediately prior to use, the user must remove the protective needle cover from the medical injection device. The force needed to remove a needle cover is measured by a physical parameter called “pull out force” (also referred to as “POF”). The pull out force necessary for removing the known needle covers from an injection device, such as a syringe, may be quite high and is due in particular to the pressure exerted onto the tip by the inner needle shield which results in friction between the inner needle shield and the tip.
As a consequence, a user having a reduced strength, for example weakened by a disease, may not be able to remove the needle shield and use the injection device for his treatment.
Moreover, healthcare professional who often use injection devices, such as nurses, have a high risk of injuring themselves, since they may not control the force they apply for pulling off the needle cover from the injection device, which may result in uncontrolled and dangerous movements. Lastly, the needle of the syringe may be bent during the removing of the needle shield because of this high required pull out force.
In view of the problems identified above, there is a current need for a needle cover that allows reducing the pull out force needed for removing said needle cover from a medical injection device, and that does not decrease the tight sealing of said needle cover to the tip of the medical injection device (while keeping intact the no leakage property of the needle cover).
In one example of the present disclosure, a needle cover for protecting a needle mounted on a tip of a barrel of a medical injection device, wherein the tip extends from a distal end of the barrel, may include an inner shield extending along a longitudinal axis, including an inner proximal connection element configured to sealingly contact the tip of the barrel, and an outer shield surrounding at least partially the inner shield, and fixed to said inner shield, wherein said outer shield of the needle cover may include a body including a first open end, a second end, and a sidewall extending between the first end and the second end, the body defining a cavity to receive an inner shield therein, and an undercut defined adjacent the first open end of the body.
In another example of the present disclosure, the outer shield of the needle cover further comprises a second undercut defined adjacent the first open end of the body, wherein a longitudinal length of the first undercut extending from the first open end towards the second end is less than a longitudinal length of the second undercut extending from the first open end towards the second end.
In another example of the present disclosure, a distance from the first open end of the outer shield to a proximal edge of the first undercut present on the body of the outer shield is greater than a distance from the first open end of the outer shield to a proximal edge of the second undercut present on the body of the outer shield. A first latching tab may extend from an inner surface of the body of the outer shield proximate the first undercut, and a second latching tab may extend from the inner surface of the body of the outer shield proximate the second undercut. The first latching tab may have a circumferential width that is greater than a circumferential width of the second latching tab. The first and second latching tabs may include a proximal angled surface. A difference between a distance from the first open end of the outer shield to a proximal edge of the first undercut and a distance from the first open end of the outer shield to a proximal edge of the second undercut may be at least 1 millimeter. The first and second undercuts may be diametrically opposed to one another. The first and second undercuts may be rectangular in shape.
Moreover, the body may define at least one U-shaped groove on an outer surface thereof. The U-shaped groove may include a distal wall and a proximal wall that extend radially from the body. A distance from the first open end of the outer shield to a distal edge of the first undercut may be equal to a distance from the first open end of the outer shield to a distal edge of the second undercut.
In another example of the present disclosure, a medical assembly, comprising: a medical injection device, comprising: a barrel defining a reservoir adapted to contain a medical composition; a tip extending from a distal face of the barrel, defining a fluid path extending through the tip and in fluid communication with the reservoir, a needle being in communication with the reservoir; and a needle cover adapted to cover the needle; characterized in that: the needle cover comprises: an inner shield extending along a longitudinal axis, comprising an inner proximal connection element configured to sealingly contact the tip of the barrel; and an outer shield covering at least a portion of the inner shield, the outer shield comprising: a body including a first open end, a second end, and a sidewall extending between the first end and the second end, the body defining a cavity to receive the inner shield therein; and a first undercut defined adjacent the first open end of the body.
Advantageously, the outer shield of the medical assembly further comprises a second undercut distinct from the first undercut and defined adjacent the first open end of the body, wherein a longitudinal length of the first undercut extending from the first open end of the outer shield towards the second end of the outer shield is less than a longitudinal length of the second undercut extending from the first open end of the outer shield towards the second end of the outer shield.
The following clauses also are directed to the present invention and disclosure:
Clause 1: A needle cover for protecting a needle mounted on a tip of a barrel of a medical injection device, wherein the tip extends from a distal end of the barrel, the needle cover comprising: an inner shield extending along a longitudinal axis, comprising an inner proximal connection element configured to sealingly contact the tip of the barrel, and an outer shield surrounding at least partially the inner shield, and fixed to said inner shield, wherein the outer shield comprises a body including a first open end, a second end, and a sidewall extending between the first end and the second end, the body defining a cavity to receive an inner shield therein; and a first undercut defined adjacent the first open end of the body.
Clause 2: The needle cover of Clause 1, wherein the body of the outer shield further comprises a second undercut defined adjacent the first open end of the body, wherein a longitudinal length of the first undercut extending from the first open end of the outer shield towards the second end is less than a longitudinal length of the second undercut extending from the first open end of the outer shield towards the second end.
Clause 3: The needle cover of Clause 2, wherein a distance from the first open end to a proximal edge of the first undercut is greater than a distance from the first open end to a proximal edge of the second undercut.
Clause 4: The needle cover of Clause 2, further comprising: a first latching tab that extends from an inner surface of the body proximate the first undercut; and a second latching tab that extends from the inner surface of the body proximate the second undercut.
Clause 5: The needle cover of Clause 4, wherein the first latching tab has a circumferential width that is greater than a circumferential width of the second latching tab.
Clause 6: The needle cover of Clause 4, wherein the first and second latching tabs comprise a proximal angled surface.
Clause 7: The needle cover of Clause 2, wherein a difference between a distance from the first open end to a proximal edge of the first undercut and a distance from the first open end to a proximal edge of the second undercut is at least 1 millimeter.
Clause 8: The needle cover of Clause 2, wherein the first and second undercuts are diametrically opposed to one another.
Clause 9: The needle cover of Clause 2, wherein the first and second undercuts are rectangular in shape.
Clause 10: The needle cover of Clause 1, wherein the body defines at least one U-shaped groove on an outer surface thereof.
Clause 11: The needle cover of Clause 10, wherein the U-shaped groove comprises a distal wall and a proximal wall that extend radially from the body.
Clause 12: The needle cover of Clause 2, wherein a distance from the first open end to a distal edge of the first undercut is equal to a distance from the first open end to a distal edge of the second undercut.
Clause 13: The needle cover of Clause 2, wherein the outer shield is fixed to the inner shield by a snap-fit connection, the inner proximal connection element of the inner shield is inserted in the first and second undercuts of the outer shield to form the snap-fit connection so that, when a pulling force is applied to the outer shield in a distal direction, the inner shield makes a first contact with end surface of the first undercut and then with an end surface of the second undercut, thereby flexing the inner shield in a radial direction to assist disengagement of the inner shield from the tip.
Clause 14: A medical assembly, comprising: a medical injection device, comprising: a barrel defining a reservoir adapted to contain a medical composition; a tip extending from a distal face of the barrel, defining a fluid path extending through the tip and in fluid communication with the reservoir, a needle in communication with the reservoir; and a needle cover of any of Clauses 1 to 12 and adapted to cover the needle; characterized in that: the needle cover comprises: an inner shield extending along a longitudinal axis, comprising an inner proximal connection element configured to sealingly contact the tip of the barrel; and an outer shield covering at least a portion of the inner shield, the outer shield comprising: a body including a first open end, a second end, and a sidewall extending between the first end and the second end, the body defining a cavity to receive the inner shield therein; and a first undercut defined adjacent the first open end of the body.
Clause 15: The medical assembly of Clause 14, wherein the barrel and the tip of the medical injection device are made of glass.
The above-mentioned and other features and advantages of this disclosure, and the manner of attaining them, will become more apparent and the disclosure itself will be better understood by reference to the following descriptions of embodiments of the disclosure taken in conjunction with the accompanying drawings, wherein:
The following description is provided to enable those skilled in the art to make and use the described embodiments contemplated for carrying out the invention. Various modifications, equivalents, variations, and alternatives, however, will remain readily apparent to those skilled in the art. Any and all such modifications, variations, equivalents, and alternatives are intended to fall within the spirit and scope of the present invention.
For purposes of the description hereinafter, the terms “upper”, “lower”, “right”, “left”, “vertical”, “horizontal”, “top”, “bottom”, “lateral”, “longitudinal”, and derivatives thereof shall relate to the invention as it is oriented in the drawing figures. However, it is to be understood that the invention may assume various alternative variations, except where expressly specified to the contrary. It is also to be understood that the specific devices illustrated in the attached drawings, and described in the following specification, are simply exemplary embodiments of the invention. Hence, specific dimensions and other physical characteristics related to the embodiments disclosed herein are not to be considered as limiting.
In the following discussion, “distal” refers to a direction generally toward an end of a medical injection device adapted for contact with a patient's skin, and “proximal” refers to the opposite direction of distal, i.e., away from the end of a medical injection device. In other words, the “distal direction” is to be understood as meaning the direction of injection. The distal direction corresponds to the travel direction of the plunger during the injection, the medical composition contained initially in the barrel being expelled from the latter. The “proximal direction” is to be understood as meaning the opposite direction to said direction of injection. For purposes of this disclosure, the above-mentioned references are used in the description of the components of a medical injection device in accordance with the present disclosure.
Referring to
The medical injection device 10 further includes a distal tip 35 extending along the axis X from the distal face 34 of the barrel 18. The distal tip 35 is at least partially hollow so as to form a fluid path in fluidic communication with the barrel 18. A needle 14 may be attached to the distal tip 35 of the injection device 10 and is in fluid communication with the fluid path. It is noted herein that the distal face 34 of the barrel 18 is proximate the shoulder of the medical injection device.
The medical injection device 10 is preferably made of glass, and more preferably is a glass syringe. Such glass syringes are largely used in hospital environments and readily sterilizable. The medical injection device 10 is preferably a prefilled syringe. The medical injection device 10 is more preferably a syringe with a staked needle.
Referring to
Referring to
The outer shield 101 includes a body 102 having a proximal end 104 and a distal end 106. Said body 102 extends along a longitudinal axis Y. Said axis Y coincides with the axis X when the needle cover 100 is mounted on the tip 35 of the medical injection device 10.
In one example, the body 102 may be substantially cylindrical in shape. The body 102 may define an inner cavity 108 (see
In another example shown in
With reference to
In one example, at least one of the undercuts 120, 122, preferably both undercuts 120, 122, may be substantially rectangular in shape. In one example, the undercuts 120, 122 may be diametrically opposed from one another on the collar 110. A longitudinal length A of the first undercut 120 may be less than a longitudinal length B of the second undercut 122. The longitudinal length A may be measured from a proximal surface 124 of the first undercut 120 to a distal surface 126 of the first undercut 120. The longitudinal length B may be measured from a proximal surface 128 of the second undercut 122 to a distal surface 130 of the second undercut 122. In another example, the distance from the proximal end 104 of the body 102 to the distal surface 126 of the first undercut 120 is substantially equal to a distance from the proximal end 104 of the body 102 to the distal surface 130 of the second undercut 122. When the longitudinal lengths A, B of the undercuts 120, 122 are different from one another, the undercuts 120, 122 are considered asymmetric from one another. In another example, a distance from the proximal end 104 of the body 102 to the proximal surface 124 of the first undercut 120 is greater than a distance from the proximal end 104 of the body 102 to the proximal surface 128 of the second undercut 122. In one example, the undercuts 120, 122 are extruded from the collar 110 of the body 102. It is also contemplated that any other manufacturing methods may be used to define the undercuts 120, 122 in the collar 110. Advantageously, the two undercuts 120, 122 are distinct from each other and define two different apertures in the collar 110.
With reference to
With reference to
The inner shield 30 is preferably made in a material with elastomeric properties. In this way, the inner proximal connection part 140 may slightly deform when connecting the inner shield 30 to the injection device 10 so as to match the shape of the tip 35. Meanwhile, the needle tip, or distal part of the needle 14, may penetrate the inner shield 30. This further reduces the risk of leakage of the medical composition via the needle 14 to the external environment. The material with elastomeric properties is preferably a thermoplastic elastomer, an elastomer, or a rubber. Preferably, the material with elastomeric properties is sterilizable.
In one embodiment, the outer shield 101 surrounds at least partially the inner shield 30. The outer needle shield 101 is fixed to the inner needle shield 30. To this end, the inner proximal connection part 140 of the inner shield 30 is partially inserted in the two undercuts 120, 122, in a snap-fit connection. The inner proximal connection part 140 of the inner shield 30 abuts both the proximal surfaces 124, 128 and the distal surfaces 126, 130 of both the undercuts 120, 122, thereby preventing any translational movement of the inner shield 30 along the axis Y relative to the outer shield 101. Advantageously, the inner proximal connection part 140 also abuts the side surfaces of the undercuts 120, 122, thereby preventing any rotational movement of the inner shield 30 around the axis Y relative to the outer needle shield 101.
The inner shield 30 and the outer shield 101 may be fixed together by other fixing means than the snap-fit connection of the undercuts 120, 122, and the inner proximal connection part 140 or in addition to said snap-fit connection. When the needle cover 100 is mounted on the injection device 10, the inner shield 30 encloses at least a portion of the tip 35 of the barrel 18, and the proximal connection part 140 firmly contacts a proximal portion of the tip 35. The needle cover 100 is thus tightly and sealingly connected to the tip 35.
In order to mount the needle cover 100 on the syringe, the outer shield 101 is firstly placed over the inner shield 30, and then the entire needle cover 100 is mounted on the syringe. As previously described, when the inner shield 30 and the outer shield 101 are fixed together, the proximal connection part 140 of the inner shield 30 will be locked into the undercuts 120, 122 defined in the collar 110 of the outer shield 101. Once locked into the undercuts 120, 122, the proximal connection part 140 is prevented from moving in a distal direction due to the distal surfaces 126, 130 of the undercuts 120, 122 and is prevented from moving in a proximal direction due to the proximal surfaces 124, 128 of the undercuts 120, 122.
After the needle cover 100 has been positioned on the medical injection device 10, the needle cover 100 can be moved in a distal direction to remove it from the medical injection device 10. As a pulling force is applied to the outer shield 101 by a user, the outer shield 101 is moved in the distal direction along with the inner shield 30. As the outer shield 101 is moved in the distal direction, the proximal surface 124 of the first undercut 120 will begin to contact and abut the proximal connection part 140 of the inner shield 30. Once the proximal surface 124 of the undercut 120 contacts the proximal connection part 140, the proximal surface 124 begins to push the proximal connection part 140 in a distal direction. As the proximal connection part 140 is pushed in the distal direction, the proximal connection part 140 begins to flex such that a collar 142 of the inner shield 30 is pulled in a radial direction away from the medical injection device 10.
As the proximal connection part 140 is pulled away in the radial direction due to contact with the proximal surface 124 of the first undercut 120, the opposing side of the proximal connection part 140 is flexed towards the proximal surface 128 of the second undercut 122. Due to the engagement between the opposing side of the proximal connection part 140 and the proximal surface 128, the second undercut 122 begins to assist in pulling the inner shield 30 off of the syringe tip 35 of the medical injection device 10. Once the outer shield 101 has been pulled a sufficient distance, the inner shield 30 is pulled off of the syringe tip 35 of the medical injection device 10.
All of the components of the medical injection device 10 may be constructed of any known material, and are desirably constructed of medical-grade polymers.
While this disclosure has been described as having exemplary designs, the present disclosure can be further modified within the spirit and scope of this disclosure. This application is therefore intended to cover any variations, uses, or adaptations of the disclosure using its general principles. Further, this application is intended to cover such departures from the present disclosure as come within known or customary practice in the art to which this disclosure pertains and which fall within the limits of the appended claims.
The application will be further described with the non-limited example below.
Example Measurement of the Pull Out Force
Measurement of the pull out force.
Needle covers including an inner shield and an outer shield of the prior art (which the outer shield does not include any undercut) or outer shield of the invention, both being previously mounted onto the tip of a glass syringe, are compared herein. The glass syringes are identical for both the needle covers of the prior art and the needle covers of the invention.
In these assays, 5 outer shields of the prior art and 5 outer shields of the invention provided with two undercuts as described in the invention are provided.
Measurements of the force needed to remove the needle cover from the syringe are carried out. The test is performed with a traction bench (500 mm/min). The method includes the steps of: placing the syringe on a holder, holding the needle cover with pneumatic jaws, and pulling the needle cover at a constant displacement rate to remove it. The force needed to pull the needle cover so as to remove it from the tip is recorded. The results are represented in the table here below.
The force recorded is the maximum value of the force needed to remove the needle cover recorded in function of time. Said force is the pull-out force, named “POF value”. As visible in Table 1, the mean value of the POF recorded for the needle cover of the prior art is 17.48 N and the mean value of the POF recorded for the needle cover of the invention is 12.49. These values of the pull out force clearly show that the needle cover of the invention leads to a strong decrease of the pull out force compared to the known needle covers. The pull out force reduction is about 29%.
| Number | Date | Country | Kind |
|---|---|---|---|
| 19305540 | Apr 2019 | EP | regional |
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/EP2020/061485 | 4/24/2020 | WO |
| Publishing Document | Publishing Date | Country | Kind |
|---|---|---|---|
| WO2020/216918 | 10/29/2020 | WO | A |
| Number | Name | Date | Kind |
|---|---|---|---|
| 2864364 | Mizzy | Dec 1958 | A |
| 3931815 | Takatsuki | Jan 1976 | A |
| 4248246 | Ikeda | Feb 1981 | A |
| 4317446 | Ambrosio et al. | Mar 1982 | A |
| 4468223 | Minagawa et al. | Aug 1984 | A |
| 4551138 | Shinohara | Nov 1985 | A |
| 4573977 | Crawford | Mar 1986 | A |
| 4735311 | Lowe et al. | Apr 1988 | A |
| 4964866 | Szwarc | Oct 1990 | A |
| 4986818 | Imbert et al. | Jan 1991 | A |
| 5085647 | Henderson et al. | Feb 1992 | A |
| 5098400 | Crouse et al. | Mar 1992 | A |
| 5147325 | Mitchell et al. | Sep 1992 | A |
| 5217025 | Okamura | Jun 1993 | A |
| 5451213 | Teicher et al. | Sep 1995 | A |
| 5484413 | Gevorgian | Jan 1996 | A |
| 5505705 | Galpin et al. | Apr 1996 | A |
| 5709659 | Bennwik et al. | Jan 1998 | A |
| 5980495 | Heinz et al. | Nov 1999 | A |
| 6015396 | Buttgen et al. | Jan 2000 | A |
| 6355017 | Buttgen et al. | Mar 2002 | B2 |
| 6485474 | Heinz et al. | Nov 2002 | B1 |
| 6544233 | Fukui et al. | Apr 2003 | B1 |
| 6551286 | Claessens | Apr 2003 | B1 |
| 6695819 | Kobayashi | Feb 2004 | B2 |
| 6719732 | Courteix | Apr 2004 | B2 |
| 7094223 | Brunel | Aug 2006 | B2 |
| 7331941 | Vetter et al. | Feb 2008 | B2 |
| 7387617 | Wittland et al. | Jun 2008 | B2 |
| 7559919 | Pech et al. | Jul 2009 | B2 |
| 7641636 | Moesli et al. | Jan 2010 | B2 |
| 7722572 | Sprinkle et al. | May 2010 | B2 |
| 7771368 | Nakamura et al. | Aug 2010 | B2 |
| 8057441 | Tsubota | Nov 2011 | B2 |
| 8096977 | Ayiyama et al. | Jan 2012 | B2 |
| 8123724 | Gillespie, III | Feb 2012 | B2 |
| 8277421 | Koyama et al. | Oct 2012 | B2 |
| 8372105 | Nishiuchi et al. | Feb 2013 | B2 |
| 8425468 | Weston | Apr 2013 | B2 |
| 8460212 | Nakamura et al. | Jun 2013 | B2 |
| 8469985 | Nishiuchi | Jun 2013 | B2 |
| 8512295 | Evans et al. | Aug 2013 | B2 |
| 8657780 | Palmer-Felgate | Feb 2014 | B2 |
| 8672894 | Bonnet | Mar 2014 | B2 |
| 8734402 | Sharp et al. | May 2014 | B2 |
| 8747357 | Stamp et al. | Jun 2014 | B2 |
| 8771235 | Chevallier et al. | Jul 2014 | B2 |
| 8858507 | Nielsen et al. | Oct 2014 | B2 |
| 8858508 | Lavi et al. | Oct 2014 | B2 |
| 8900197 | Crow | Dec 2014 | B2 |
| 8913123 | Miller | Dec 2014 | B2 |
| 8961460 | Yokota et al. | Feb 2015 | B2 |
| 9084854 | Evans et al. | Jul 2015 | B2 |
| 9132266 | Hayakawa et al. | Sep 2015 | B2 |
| 9192729 | Iwase et al. | Nov 2015 | B2 |
| 9248245 | Ekman et al. | Feb 2016 | B2 |
| 9278179 | Schoonmaker | Mar 2016 | B2 |
| 9295785 | Ekman et al. | Mar 2016 | B2 |
| 9302053 | Holmqvist | Apr 2016 | B2 |
| 9314574 | Roberts et al. | Apr 2016 | B2 |
| 9333305 | McLoughlin et al. | May 2016 | B2 |
| 9339600 | Weston | May 2016 | B2 |
| 9339610 | Julian et al. | May 2016 | B2 |
| 9352099 | Roberts et al. | May 2016 | B2 |
| 9415176 | Benson et al. | Aug 2016 | B1 |
| 9468724 | Evans et al. | Oct 2016 | B2 |
| 9468726 | Lundquist | Oct 2016 | B2 |
| 9545484 | Bicknell et al. | Jan 2017 | B2 |
| 9545485 | Takemoto | Jan 2017 | B2 |
| 9757526 | Iwase et al. | Sep 2017 | B2 |
| 9808584 | Takemoto | Nov 2017 | B2 |
| 9839752 | Fournier et al. | Dec 2017 | B2 |
| 9861761 | Gonzales et al. | Jan 2018 | B2 |
| 9867950 | Takemoto | Jan 2018 | B2 |
| 9919107 | Imai et al. | Mar 2018 | B2 |
| 9919109 | Arinobe et al. | Mar 2018 | B2 |
| 9925327 | Okihara et al. | Mar 2018 | B2 |
| RE46789 | Olson | Apr 2018 | E |
| 9950124 | Imai et al. | Apr 2018 | B2 |
| 9962497 | Takemoto | May 2018 | B2 |
| 9962498 | Horita et al. | May 2018 | B2 |
| 10369289 | Cabiri et al. | Aug 2019 | B2 |
| 10537688 | Wittland et al. | Jan 2020 | B2 |
| 10653848 | Wittland et al. | May 2020 | B2 |
| 11040148 | Swal et al. | Jun 2021 | B2 |
| 11305062 | Fabien et al. | Apr 2022 | B2 |
| 20040186440 | Jansen et al. | Sep 2004 | A1 |
| 20050215952 | Brunel et al. | Sep 2005 | A1 |
| 20060212021 | Yazaki et al. | Sep 2006 | A1 |
| 20070250016 | Pech et al. | Oct 2007 | A1 |
| 20080183140 | Paproski et al. | Jul 2008 | A1 |
| 20080215013 | Felix-Faure | Sep 2008 | A1 |
| 20080269690 | Felix-Faure | Oct 2008 | A1 |
| 20090118678 | Kawashima | May 2009 | A1 |
| 20090124981 | Evans | May 2009 | A1 |
| 20100145227 | Wessel | Jun 2010 | A1 |
| 20110118568 | Sei | May 2011 | A1 |
| 20110202035 | Voellmicke et al. | Aug 2011 | A1 |
| 20120179109 | Takemoto et al. | Jul 2012 | A1 |
| 20120191048 | Eaton | Jul 2012 | A1 |
| 20120238961 | Julian | Sep 2012 | A1 |
| 20120330243 | Liversidge | Dec 2012 | A1 |
| 20130012886 | Kawachi | Jan 2013 | A1 |
| 20130030365 | Liversidge | Jan 2013 | A1 |
| 20130053788 | Dugand et al. | Feb 2013 | A1 |
| 20130072882 | Ogawa et al. | Mar 2013 | A1 |
| 20130123711 | Schoonmaker et al. | May 2013 | A1 |
| 20130174518 | Tachikawa et al. | Jul 2013 | A1 |
| 20130204197 | Bicknell et al. | Aug 2013 | A1 |
| 20130261563 | Zachek | Oct 2013 | A1 |
| 20130274677 | Ekman et al. | Oct 2013 | A1 |
| 20130296801 | Takemoto et al. | Nov 2013 | A1 |
| 20140025013 | Dowds et al. | Jan 2014 | A1 |
| 20140107577 | Boyd et al. | Apr 2014 | A1 |
| 20140221873 | Hayakawa et al. | Aug 2014 | A1 |
| 20140236102 | Matsumoto et al. | Aug 2014 | A1 |
| 20140249479 | Pfrang | Sep 2014 | A1 |
| 20140343503 | Holmqvist | Nov 2014 | A1 |
| 20150174329 | Takemoto | Jun 2015 | A1 |
| 20150190566 | Okihara | Jul 2015 | A1 |
| 20150196720 | Okihara et al. | Jul 2015 | A1 |
| 20150217061 | Sadowski et al. | Aug 2015 | A1 |
| 20150258283 | Imai et al. | Sep 2015 | A1 |
| 20150297837 | Schraga | Oct 2015 | A1 |
| 20150335830 | Horita et al. | Nov 2015 | A1 |
| 20150352291 | Fournier et al. | Dec 2015 | A1 |
| 20160001006 | Takemoto et al. | Jan 2016 | A1 |
| 20160001013 | Fournier et al. | Jan 2016 | A1 |
| 20160001015 | Kucuk et al. | Jan 2016 | A1 |
| 20160008553 | Fournier et al. | Jan 2016 | A1 |
| 20160015905 | Fournier et al. | Jan 2016 | A1 |
| 20160106929 | Fournier et al. | Apr 2016 | A1 |
| 20160175539 | Riedel et al. | Jun 2016 | A1 |
| 20160206829 | Protasiewicz et al. | Jul 2016 | A1 |
| 20160220766 | Kawano et al. | Aug 2016 | A1 |
| 20160243305 | Nakamura et al. | Aug 2016 | A1 |
| 20160243315 | Perche et al. | Aug 2016 | A1 |
| 20160271338 | Fournier et al. | Sep 2016 | A1 |
| 20160271848 | Takemoto et al. | Sep 2016 | A1 |
| 20160287810 | Keim et al. | Oct 2016 | A1 |
| 20160296713 | Schader et al. | Oct 2016 | A1 |
| 20160310676 | Darras et al. | Oct 2016 | A1 |
| 20160325051 | Keim et al. | Nov 2016 | A1 |
| 20160331904 | Huthmacher et al. | Nov 2016 | A1 |
| 20160331908 | Bode | Nov 2016 | A1 |
| 20160354550 | Ward et al. | Dec 2016 | A1 |
| 20160354551 | Keim et al. | Dec 2016 | A1 |
| 20160354552 | Keim et al. | Dec 2016 | A1 |
| 20160367756 | Felts et al. | Dec 2016 | A1 |
| 20170014578 | Bunch | Jan 2017 | A1 |
| 20170021103 | Mosebach et al. | Jan 2017 | A1 |
| 20170080159 | Wei | Mar 2017 | A1 |
| 20170143893 | Hasumi et al. | May 2017 | A1 |
| 20170182259 | Fukushi et al. | Jun 2017 | A1 |
| 20170189603 | Okihara et al. | Jul 2017 | A1 |
| 20170197040 | Funatsu et al. | Jul 2017 | A1 |
| 20170203052 | Abe et al. | Jul 2017 | A1 |
| 20170224932 | Fournier et al. | Aug 2017 | A1 |
| 20170274151 | Allen | Sep 2017 | A1 |
| 20170326306 | Grosser | Nov 2017 | A1 |
| 20170361030 | Moore | Dec 2017 | A1 |
| 20180011417 | Shimizu et al. | Jan 2018 | A1 |
| 20180015229 | Iwase | Jan 2018 | A1 |
| 20180015230 | Okihara | Jan 2018 | A1 |
| 20180028762 | Maxfield | Feb 2018 | A1 |
| 20180064885 | Yamazaki et al. | Mar 2018 | A1 |
| 20180085534 | Gonzales et al. | Mar 2018 | A1 |
| 20180104421 | Wittland et al. | Apr 2018 | A1 |
| 20180110934 | Wittland et al. | Apr 2018 | A1 |
| 20180140783 | Raday | May 2018 | A1 |
| 20180161511 | Fraas et al. | Jun 2018 | A1 |
| 20180272075 | Stefanov et al. | Sep 2018 | A1 |
| 20180304030 | Julian et al. | Oct 2018 | A1 |
| 20180311442 | Saussaye et al. | Nov 2018 | A1 |
| 20180353702 | Jugl | Dec 2018 | A1 |
| 20190201634 | Newton | Jul 2019 | A1 |
| 20200061302 | Alexandersson | Feb 2020 | A1 |
| 20210220565 | Frost | Jul 2021 | A1 |
| Number | Date | Country |
|---|---|---|
| 105007969 | Jan 2018 | CN |
| 105007970 | May 2018 | CN |
| 10316127 | Nov 2004 | DE |
| 102011014200 | Feb 2014 | DE |
| 102011017275 | Apr 2014 | DE |
| 102013112654 | May 2015 | DE |
| SP077339 | Apr 2007 | EC |
| 0498737 | Jul 1995 | EP |
| 2172238 | Apr 2010 | EP |
| 2548596 | Jan 2013 | EP |
| 3325054 | Mar 2021 | EP |
| 2777787 | Apr 2001 | FR |
| 3003469 | Apr 2016 | FR |
| 1235347 | Jun 1971 | GB |
| 249004 | Jan 2021 | IL |
| 257906 | Jan 2022 | IL |
| S5519160 | Feb 1980 | JP |
| H01212563 | Aug 1989 | JP |
| 200754194 | Mar 2007 | JP |
| 6042816 | Dec 2016 | JP |
| 1020180006383 | Jan 2018 | KR |
| 8900830 | Feb 1989 | WO |
| 8908468 | Sep 1989 | WO |
| 2007082226 | Jul 2007 | WO |
| 2008016710 | Feb 2008 | WO |
| 2008041437 | Apr 2008 | WO |
| 2009104765 | Aug 2009 | WO |
| 2011068130 | Jun 2011 | WO |
| 2011068131 | Jun 2011 | WO |
| 2011122393 | Oct 2011 | WO |
| 2011122395 | Oct 2011 | WO |
| 2011125475 | Oct 2011 | WO |
| 2011125561 | Oct 2011 | WO |
| 2012082818 | Jun 2012 | WO |
| 2012133267 | Oct 2012 | WO |
| 2013046857 | Apr 2013 | WO |
| 2013047149 | Apr 2013 | WO |
| 2013145998 | Oct 2013 | WO |
| 2013146000 | Oct 2013 | WO |
| 2013146099 | Oct 2013 | WO |
| 2013146215 | Oct 2013 | WO |
| 2013172104 | Nov 2013 | WO |
| 2013183464 | Dec 2013 | WO |
| 2013190941 | Dec 2013 | WO |
| 2014033873 | Mar 2014 | WO |
| 2014049797 | Apr 2014 | WO |
| 2014115241 | Jul 2014 | WO |
| 2014162439 | Oct 2014 | WO |
| 2014184932 | Nov 2014 | WO |
| 2015001819 | Jan 2015 | WO |
| 2015029628 | Mar 2015 | WO |
| 2015049945 | Apr 2015 | WO |
| 2015105511 | Jul 2015 | WO |
| 2015110533 | Jul 2015 | WO |
| 2015147018 | Oct 2015 | WO |
| 2016202498 | Dec 2016 | WO |
| 2016202670 | Dec 2016 | WO |
| 2017051108 | Mar 2017 | WO |
| 2017051113 | Mar 2017 | WO |
| 2017062938 | Apr 2017 | WO |
| 2017081421 | May 2017 | WO |
| 2018011417 | Jan 2018 | WO |
| 2018172853 | Sep 2018 | WO |
| 2019074788 | Apr 2019 | WO |
| Number | Date | Country | |
|---|---|---|---|
| 20220184322 A1 | Jun 2022 | US |